Purpose-built for physicians GLP-1RAs improve ALT in pediatric MASLD, could be powerful option for some patients Key takeaways: Treatment with GLP-1RAs resulted in significant mean reductions in ALT by 23.4 U/L at 6 months and by 18.2 U/L overall
Children and adolescents Almost one in 10 children/adolescents have MASLD, with a higher prevalence among children considered obese [44,45]
The ingredients have been studied in human trials through oral delivery, which aligns with how these products are actually taken
Sterile water and normal saline can technically dissolve the powder, but the reconstituted solution must then be used within 24 hours, which is impractical for a weekly injection regimen
JPMorgan estimates the growing use of the medications could wipe out $30 billion to $55 billion in annual sales for the food and beverage industry as soon as 2030
Track waist circumference, hip circumference, and other relevant measurements monthly